SCHEMBL22154282

SCHEMBL22154282

N#Cc1ccc2c3ccc(-n4c5ccccc5c5ccccc54)cc3n(-c3ccc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3C#N)c2c1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP14 P54578 3/20 0.33
HDAC4 P56524 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDPK1 O15530 1/20 0.32
IMPDH2 P12268 1/20 0.31
FLT3 P36888 1/20 0.31
PGR P06401 1/20 0.31
G6PD P11413 1/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22152381 1.00 KDM4E (0.36) KDM4EATML3MBTL1USP14HDAC4
SCHEMBL22153743 1.00 KDM4E (0.36) KDM4EATML3MBTL1USP14HDAC4
SCHEMBL22153813 1.00 KDM4E (0.36) KDM4EATML3MBTL1USP14HDAC4
SCHEMBL22154285 0.97 KDM4E (0.34) KDM4EATML3MBTL1USP14HDAC4
SCHEMBL22152409 0.95 KDM4E (0.35) KDM4EATML3MBTL1USP14HDAC4
SCHEMBL22153218 0.95 KDM4E (0.35) KDM4EATML3MBTL1USP14HDAC4
SCHEMBL22152408 0.95 KDM4E (0.35) KDM4EATML3MBTL1USP14HDAC4
SCHEMBL22152787 0.95 KDM4E (0.35) KDM4EATML3MBTL1USP14HDAC4
SCHEMBL22153745 0.95 KDM4E (0.35) KDM4EATML3MBTL1USP14HDAC4
SCHEMBL22153176 0.95 KDM4E (0.35) KDM4EATML3MBTL1USP14HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 KDM4E 3084/4885ATM 994/4885L3MBTL1 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.